Pharmacists in Taylorville, Illinois


13 Pharmacists found in Taylorville
male pharmacist

Andrew Moore, PHARM.D


Pharmacist
1530 W Springfield Rd, Taylorville, IL 62568
217-287-1121    

female pharmacist

Brittany Ondes, PHARMD


Pharmacist
401 N Webster St, Taylorville, IL 62568
217-287-7951    

male pharmacist

Mr. Daniel Kevin Curl, PHARMD


Pharmacist
315 N Webster St, Taylorville, IL 62568
217-824-8154     217-824-8165



male pharmacist

Mr. David K Driskell, R.PH.


Pharmacist
315 N Webster St, Taylorville, IL 62568
217-824-8154    

female pharmacist

Emily Gibson


Pharmacist
1530 W Springfield Rd, Taylorville, IL 62568
217-287-1121    

female pharmacist

Gina Berg Thompson, RPH


Pharmacist
315 N Webster St, Taylorville, IL 62568
217-824-8154     217-824-8165

male pharmacist

Gordon John Mazzotti, R PH


Pharmacist
315 N Webster St, Taylorville, IL 62568
217-824-8154    

male pharmacist

Mr. James Ballew Maple, R.PH.


Pharmacist
201 E Pleasant St, Taylorville, IL 62568
217-824-1668     217-824-1671

male pharmacist

Jon Livingston, RPH


Pharmacist
1530 W Springfield Rd, Taylorville, IL 62568
217-287-1121     217-287-1114

female pharmacist

Dr. Lisa Marie Cunningham


Pharmacist
401 N Webster St, Taylorville, IL 62568
217-287-7951     217-287-2639

male pharmacist

Mr. Paul Vincent Chausse, RPH


Pharmacist
1530 W Springfield Rd, Taylorville, IL 62568
217-287-1121    

male pharmacist

Richard R Mazzotti, RPH


Pharmacist
315 N Webster St, Taylorville, IL 62568
217-824-8154    

female pharmacist

Tracy N Garwood


Pharmacist
1530 W Springfield Rd, Taylorville, IL 62568
217-287-1121    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.